| Patents for A61P 19 - Drugs for skeletal disorders (81,981) |
|---|
| 04/04/2007 | CN1308001C Quality control method of hyperasteogeny-treating medicinal capsule |
| 04/04/2007 | CN1307999C Mixed-cell gene therapy |
| 04/04/2007 | CN1307993C Macrolides-containing pharmaceutical compositions |
| 04/04/2007 | CN1307976C Thorax comforting drop pills for treating cardiopathy and preparation method thereof |
| 04/03/2007 | US7200531 Conformation-activity relationship of apoptosis-inducing phosphodiester oligonucleotides |
| 04/03/2007 | US7199265 Thyroid receptor ligands, pharmaceutical compositions comprising them and their use in the treatment of disorders influenced by thyroid hormones |
| 04/03/2007 | US7199228 Nucleotide sequences comprising nebularine, hypoxanthine and uracil; antitumor agents; antiproliferative agents; anticarcinogenic agents; antiinflammatory agents |
| 04/03/2007 | US7199225 Stimulating differentiation in growth of osteoblasts and osteoclasts; wound healing of bone fractures and de novo bone formation; osteoporosis; bone cancer treatment; polynucleotide encoding polypeptide; genetic engineering |
| 04/03/2007 | US7199219 Polypeptides derived from vitamin D nuclear receptor, and their uses in particular for screening vitamin D analogues |
| 04/03/2007 | US7199152 TNF-α production inhibitor comprising kavalactone as an active ingredient |
| 04/03/2007 | US7199150 Amino alcohol compounds |
| 04/03/2007 | US7199147 Rho kinase inhibitors |
| 04/03/2007 | US7199145 Derivatives of hydantoins, thiohydantoins, pyrimidinediones and thioxopyrimidinones, their preparation processes and their use as medicaments |
| 04/03/2007 | US7199142 1-((5-aryl-1,2,4-oxadiazol-3-yl) benzyl)azetidine-3-carboxylates and 1-((5-aryl-1,2,4-oxadiazol-3-yl)benzyl) pyrrolidine-3-carboxylates as edg receptor agonists |
| 04/03/2007 | US7199130 Substituted 5,6,6a, 11b-tetrahydro-7-oxa-5-aza-benzo[c]fluorene-6-carboxylic acid compounds as NMDA-antagonists |
| 04/03/2007 | US7199122 Administering 5-(2-pyrazinyl)-4-methyl-1,2-dithiol-3-thione and/or metabolite thereof; treating neoplastic diseases, atherosclerosis, restenosis, rheumatoid arthritis, Crohn's disease, diabetic retinopathy, psoriasis, and endometriosis |
| 04/03/2007 | US7198944 for the treatment of leukemia, tumors, chronic infections, autoimmune disease, fibrotic disorders, wound healing and psoriasis |
| 04/03/2007 | US7198913 Nucleotide sequences coding polypeptide for use in the treatment of apoptosis, inflammatory and autoimmune disorders |
| 04/03/2007 | US7198911 Identification and cloning of a novel human gene, RET16, involved in the intracellular signaling cascade |
| 04/03/2007 | US7198910 Nucleic acid encoding melanin-concentrating hormone receptor |
| 04/03/2007 | US7198802 Tablet obtained by direct compression comprising 4-amino-1-hydroxybutylidene-1,1-bisphosphonic acid as active ingredient |
| 04/03/2007 | US7198790 Growth differentiation factor-5 |
| 04/03/2007 | US7198254 System for producing micro-cluster liquids |
| 04/03/2007 | CA2419573C Method of increasing testosterone and related steroid concentrations in women |
| 04/03/2007 | CA2388452C Oxa- and thiazole derivatives useful as antidiabetic and antiobesity agents |
| 04/03/2007 | CA2294581C Angiogenesis inhibiting 5-substituted-1,2,4-thiadiazolyl derivatives |
| 04/03/2007 | CA2181006C N,n-diethyl-8,8-dipropyl-2-azaspiro[4,5]decane-2-propanamine dimaleate |
| 04/03/2007 | CA2176943C Mutants of bone morphogenetic proteins |
| 04/03/2007 | CA2108770C Bmp-9 compositions |
| 03/29/2007 | WO2007035406A1 Antibodies to complementary peptides of thrombin or portions thereof |
| 03/29/2007 | WO2007035309A1 Tyrosine kinase inhibitors |
| 03/29/2007 | WO2007034477A2 Modulation of osteoclast differentiation |
| 03/29/2007 | WO2006128142A3 Inhibitors of cytosolic phospholipase a2 |
| 03/29/2007 | WO2006110883A3 Methods for treating osteoarthritis pain by administering a nerve growth factor antagonist and compositions containing the same |
| 03/29/2007 | US20070072849 Tricyclic quinolinone and tricyclic quinoline androgen receptor modulator compounds and methods |
| 03/29/2007 | US20070072818 Endothelial growth factors; antiischemic agents; neovascularization |
| 03/29/2007 | US20070072801 Methods of treatment using specific binding agents of human angiopoietin-2 |
| 03/29/2007 | US20070072236 Novel type II Na/Pi cotransporters and type II Na/Pi cotransporter expression regulatory factors |
| 03/29/2007 | US20070071733 Synthetic substrate for tissue formation |
| 03/29/2007 | US20070071693 Therapeutic agent and therapeutic method for periodontal diseases and pulpal diseases |
| 03/29/2007 | DE102005045145A1 Verwendung von Octenidindihydrochlorid in halbfesten Zubereitungen Use of octenidine in semi-solid preparations |
| 03/29/2007 | CA2623205A1 Modulation of osteoclast differentiation |
| 03/28/2007 | EP1767653A1 Probe for diagnosis of marfan's syndrome and method of screening with the probe |
| 03/28/2007 | EP1767632A2 A method for local administration of synthetic double-stranded oligonucleotides targeting a VEGF receptor |
| 03/28/2007 | EP1767544A2 Methods of treatment of inflammatory diseases using specific binding agents of human angiopoietin - 2 |
| 03/28/2007 | EP1767541A1 Hla-a24- or hla-a2-binding peptide of parathyroid hormone-related protein |
| 03/28/2007 | EP1767534A1 Drug for treating or preventing duplication of hypertension with serum hyperuricemia and/or hypercholesterolemia |
| 03/28/2007 | EP1767533A1 N-{(2-(2,6-dioxo(3-piperidyl)-1,3-dioxo-2,3-dihydro-1H-isoindolin-4-yl)methyl}cyclopropylcarboxamide as TNF inhibitor |
| 03/28/2007 | EP1767531A1 Medicinal compositions containing 6-hydroxybenzbromarone or salts thereof |
| 03/28/2007 | EP1767213A2 Method for improving stability of a bone-connecting implant |
| 03/28/2007 | EP1767199A2 Methods and compositions for treatment of cancer pain |
| 03/28/2007 | EP1767198A1 Regulator of physiological function of ghrelin and use thereof |
| 03/28/2007 | EP1765796A1 Substituted heteroaryl- and phenylsulfamoyl compounds |
| 03/28/2007 | EP1765461A1 Pyk2 inhibitors for stimulation of osteoblast function |
| 03/28/2007 | EP1765366A2 Sulphated depolymerised derivates of exopolysaccharides (eps), preparation and uses thereof |
| 03/28/2007 | EP1765336A2 Angiogenesis inhibitors |
| 03/28/2007 | EP1765314A1 Pharmaceutical compositions for the treatment of disease and/or symptoms in arthritis |
| 03/28/2007 | EP1497294B1 1,2,3,4,7,8-HEXAHYDRO-6 i H /i - 1,4 DIAZEPINO 6,7 ,1- i 1J /i QUINOLINE DERIVATIVES AS ANTIPSYCHOTIC AND ANTI OBESITY AGENTS |
| 03/28/2007 | EP1335733B1 Treatment of osteoporosis |
| 03/28/2007 | EP1228071B1 Pharmaceutically active isoindoline derivatives |
| 03/28/2007 | EP1152760B1 Use of 4-amino pyridine for treatment of peripheral neuropathies |
| 03/28/2007 | CN1938274A Novel piperidines as chemokine modulators (CCR) |
| 03/28/2007 | CN1938034A ED-71 preparation |
| 03/28/2007 | CN1938019A Protein kinase C inhibitors for the treatment of autoimmune diseases and of transplant rejection |
| 03/28/2007 | CN1938018A Use of compounds that are able to increase the serum igf-1 level for the preparation of a therapeutical composition for treatment of various disease states associated with a reduced igf-1 serum level |
| 03/28/2007 | CN1936023A Diagnostic and monitoring methods for bone loss |
| 03/28/2007 | CN1935839A Analogues of glp-1 |
| 03/28/2007 | CN1935768A Vegeta tive female sex hormone eudesmane compound, and its preparing method and use |
| 03/28/2007 | CN1935260A Human antibodies that bind human tnfalpha |
| 03/28/2007 | CN1935248A Chinese medicine preparation for treating lumbar-cervical vertebra disease |
| 03/28/2007 | CN1935242A Chinese medicine composition, and its preparing method and quality control method |
| 03/28/2007 | CN1935238A Solution for activating meridians to stop pain |
| 03/28/2007 | CN1935237A Emplastrum for injury, bone, flatulence relieving and inflammation and its use |
| 03/28/2007 | CN1935223A Chinese medicine composition, and its preparing method and quality control method |
| 03/28/2007 | CN1935222A Medicinal liquor for treating traumatic injury |
| 03/28/2007 | CN1935220A Medicinal liquor for treating traumatic injury |
| 03/28/2007 | CN1935214A Joint pain pill |
| 03/28/2007 | CN1935203A Radix aconiti agrestis extract and its preparing method |
| 03/28/2007 | CN1935202A Monkshood extract and its preparing method |
| 03/28/2007 | CN1935192A Chinese medicine composition, and its preparing method and quality control method |
| 03/28/2007 | CN1935190A Medicinal liquor for treating traumatic injury |
| 03/28/2007 | CN1935189A Medicinal liquor for removing gall |
| 03/28/2007 | CN1935175A Medicinal liquor for removing gall |
| 03/28/2007 | CN1935165A Moringaceae tablet and its producing method |
| 03/28/2007 | CN1935133A Human leucocyte antigen DR4 subtype protein agonist |
| 03/28/2007 | CN1935128A Use of pogostemonis alkane type sesquiterpene compound as vegetative female sex normone |
| 03/28/2007 | CN1307199C Bone pattern generation protein 2 active peptide and its preparation method and application |
| 03/28/2007 | CN1307181C Condensed heterocyclic succimide compounds as androgen receptor modulators and their analog |
| 03/28/2007 | CN1307179C Pyrimidine derivatives for inhibition of cell proliferation |
| 03/28/2007 | CN1307176C Novel alkoxypyridine-derivatives |
| 03/28/2007 | CN1307174C Imidazoquinoline derivatives |
| 03/28/2007 | CN1307159C TNF-alpha prodn. inhibitors |
| 03/28/2007 | CN1307158C Substituted 2-pyrrole cyclohexan-1,4-diamine derivatives |
| 03/28/2007 | CN1307157C Novel compounds |
| 03/28/2007 | CN1306964C Decoy composition for treating and preventing inflammatory disease |
| 03/28/2007 | CN1306948C Capsule for treating osteoporosis and its preparing method |
| 03/27/2007 | US7196201 For therapy and prophylaxis of metabolic disorders, gastrointestinal disorders, viral disorders, inflammatory disorders, diabetes, obesity, hyperlipidemia, dermatological or mucous membrane disorders, psoriasis, intestinal distress, constipation, autoimmune disorders, encephalomyelitis |
| 03/27/2007 | US7196179 gluconic acid reaction or hydrolysis of glucono delta lactone in water with lactic acid in the presence of calcium hydroxide ; hypocalcaemia, hyperparathyroidism, osteomalacia, rickets, symptomatic treatment of osteoporosis especially in menopause, to calcify in breast milk |
| 03/27/2007 | US7196118 Amidino compounds useful as nitric oxide synthase inhibitors |
| 03/27/2007 | US7196104 (2-substituted-4-yl-thiazole)-urea-1-pyridine-2-yl derivative effective for prophylaxis and treatment of diseases, such as cell proliferation or apoptosis mediated diseases |